Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
Primary:
- to evaluate the efficacy of phenobarbital in reducing seizure frequency.
Secondary:
- to confirm dose response relationship,
- to assess the effects on Type I seizures,
- to assess the safety of phenobarbital
- to assess the drug tolerability.